Skin Manifestations associated with COVID-19
DOI:
https://doi.org/10.56294/saludcyt2022222Keywords:
COVID-19, Dermatology, Cutaneous manifestations, SARS-CoV-2Abstract
Introduction: the recognition of skin manifestations in patients with COVID-19 is very useful since its identification could help to diagnose SARS-COV-2 infection early and contribute to delaying the transmission of the virus.
Objective: determine the skin manifestations associated with Covid 19.
Methods: a narrative bibliographical review was carried out; For the search for information, Scopus and PubMed databases were used with MESH/DECS descriptors using keywords, taking into account the last five years, in English and Spanish, and with inclusion and exclusion criteria for the articles to be analyzed.
Results: in Spain, 58 patients admitted to hospital for suspected COVID-19 infection presented skin lesions such as generalized maculopapular rash (20,7 %), Livedo reticularis (6,9 %), Urticaria (6,9 %) and others non-specific eruptions in 22,4 %.
Conclusion: the most frequent lesions are urticarial rash, erythematous/maculopapular/morbilliform confluent rash, papulovesicular rash, chilblain-like acral pattern, livedo reticularis/racemose pattern, vasculitic purpuric pattern, cataloging the most frequent skin lesions to maculopapular rash that affect the trunk. and acral regions, especially toes and plantar region
References
1. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules 2020;26:39. https://doi.org/10.3390/molecules26010039.
2. Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection 2021;49:199-213. https://doi.org/10.1007/s15010-020-01516-2.
3. Morens DM, Daszak P, Markel H, Taubenberger JK. Pandemic COVID-19 Joins History’s Pandemic Legion. mBio 2020;11:e00812-20. https://doi.org/10.1128/mBio.00812-20.
4. Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med 2020;38:1715-21. https://doi.org/10.1016/j.ajem.2020.06.011.
5. Rahimi H, Tehranchinia Z. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19. Biomed Res Int 2020;2020:1236520. https://doi.org/10.1155/2020/1236520.
6. González González F, Cortés Correa C, Peñaranda Contreras E. Manifestaciones cutáneas en pacientes con COVID-19: características clínicas y mecanismos fisiopatológicos postulados. Actas Dermo-Sifiliográficas 2021;112:314-23. https://doi.org/10.1016/j.ad.2020.11.013.
7. Sharma S, Raby E, Prasad Kumarasinghe S. Cutaneous manifestations and dermatological sequelae of Covid‐19 infection compared to those from other viruses. Australas J Dermatol 2021;62:141-50. https://doi.org/10.1111/ajd.13561.
8. Drenovska K, Schmidt E, Vassileva S. Covid‐19 pandemic and the skin. Int J Dermatol 2020;59:1312-9. https://doi.org/10.1111/ijd.15189.
9. Li H, Zhao Y, Zhou L, Hu J. Cutaneous, skin histopathological manifestations and relationship to COVID‐19 infection patients. Dermatol Ther 2020;33:e14157. https://doi.org/10.1111/dth.14157.
10. Sodeifian F, Mushtaq S, Rezaei N. Manifestaciones cutáneas de la COVID-19: ¿Qué hemos aprendido tras un año de pandemia? Actas Dermo-Sifiliográficas 2022;113:T157-65. https://doi.org/10.1016/j.ad.2021.08.005.
11. Panda M, Dash S, Behera B, Sil A. Dermatological Manifestations Associated with COVID-19 Infection. Indian J Dermatol 2021;66:237-45. https://doi.org/10.4103/ijd.ijd_464_21.
12. GÜL Ü. COVID-19 and dermatology. Turk J Med Sci 2020;50:1751-9. https://doi.org/10.3906/sag-2005-182.
13. Daneshgaran G, Dubin DP, Gould DJ. Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol 2020;21:627-39. https://doi.org/10.1007/s40257-020-00558-4.
14. Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, et al. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. J Clin Med 2020;9:3261. https://doi.org/10.3390/jcm9103261.
15. Navarro-Bielsa A, nueva E a sitio externo E enlace se abrirá en una ventana, Abadías-Granado I, nueva E a sitio externo E enlace se abrirá en una ventana, Morales-Callaghan AM, Suso-Estívalez C, et al. Experience with Cutaneous Manifestations in COVID-19 Patients during the Pandemic. Journal of Clinical Medicine 2022;11. https://doi.org/10.3390/jcm11030600.
16. Farajzadeh S, Khalili M, Dehghani S, Babaie S, Fattah M, Abtahi‐Naeini B. Top 10 acral skin manifestations associated with COVID‐19: A scoping review. Dermatol Ther 2021;34:e15157. https://doi.org/10.1111/dth.15157.
17. Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, et al. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol 2021;147:857-869.e7. https://doi.org/10.1016/j.jaci.2021.01.006.
18. Sameni F, Hajikhani B, Yaslianifard S, Goudarzi M, Owlia P, Nasiri MJ, et al. COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies. Front Med (Lausanne) 2020;7:573188. https://doi.org/10.3389/fmed.2020.573188.
19. Méndez Maestro I, Peña Merino L, Udondo González del Tánago B, Aramburu González A, Orbea Sopeña A, Sánchez De Vicente J, et al. Skin manifestations in patients hospitalized with confirmed COVID‐19 disease: a cross‐sectional study in a tertiary hospital. Int J Dermatol 2020;59:1353-7. https://doi.org/10.1111/ijd.15180.
20. Carazo Gallego B, Martín Pedraz L, Galindo Zavala R, Rivera Cuello M, Mediavilla Gradolph C, Núñez Cuadros E. Lesiones cutáneas en niños durante la primera ola de la pandemia por SARS-CoV-2. Medicina Clínica 2021;157:33-7. https://doi.org/10.1016/j.medcli.2021.03.004.
21. Guzmán-Mendoza OE, Garzón-Portilla MC, Echeverry DF, López Quintero W. Characterization of skin manifestations due to SARS-COV-2 infection in Latin American patients. Piel 2022;37:S1-6. https://doi.org/10.1016/j.piel.2022.02.017.
22. Sánchez-Cárdenas CD, Farías-Hernández M, Verazaluce-Rodríguez BE, Galván-Linares AI, Moreno-Coutiño G. G. Patrones clínicos e histopatológicos de dermatosis en pacientes con infección por COVID-19 en la Unidad Médica de Alta Especialidad del Bajío, IMSS-T1, de León, Guanajuato. Rev chil infectol 2021; 38(6):745-753. http://dx.doi.org/10.4067/s0716-10182021000600745.
23. Morales González ADR. Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes. Piel 2022. https://doi.org/10.1016/j.piel.2022.07.005.
24. Galván Casas C, Català A, Carretero Hernández G, Rodríguez‐Jiménez P, Fernández‐Nieto D, Rodríguez‐Villa Lario A, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020;183:71-7. https://doi.org/10.1111/bjd.19163.
25. Jiménez-Tamayo SB, Orozco-Jiménez S, González Correa AM. Manifestaciones mucocutáneas en pacientes hospitalizados por COVID 19 en un hospital de alta complejidad. CES med 2022:30-45.
26. Dalal A, Jakhar D, Agarwal V, Beniwal R. Dermatological findings in SARS‐CoV‐2 positive patients: An observational study from North India. Dermatol Ther 2020;33:e13849. https://doi.org/10.1111/dth.13849.
Published
Issue
Section
License
Copyright (c) 2022 Jessica Alexandra Estrada Morocho, Rolando Espinoza Cárdenas, Kelly Paola Gómez Guapizaca, Glenda Iris Montenegro Ortiz (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
